V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10320375 | 10039482 | 1.5 | 72 | Curative (C) | 2016-02-07 | 2019-08-09 | CHOP R - 21 days | N | null | CHOP R | 100959756 |
| 10320429 | 10039483 | 1.74 | 59.5 | Adjuvant (A) | 2018-03-13 | 2018-03-13 | Gemcitabine + Capecitabine | 02 | N | SUNITINIB | 100872545 |
| 10320444 | 10039484 | 1.57 | 92.7 | Curative (C) | 2019-03-30 | 2019-05-17 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101172829 |
| 10320457 | 10039485 | 1.61 | 88 | Curative (C) | 2018-06-25 | 2018-06-25 | CHLORAMBUCIL + RITUXIMAB | 02 | null | CHLORAMBUCIL + RITUXIMAB | 101694398 |
| 10320488 | 10039486 | 1.7 | 93.7 | Radical (R) | 2019-09-24 | 2019-10-22 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100034048 |
| 10320532 | 10039487 | 1.68 | 89 | Disease modification (D) | 2018-02-08 | 2018-02-14 | Gemcitabine + Capecitabine | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101819757 |
| 10320539 | 10039488 | null | null | Palliative (P) | 2017-12-07 | 2017-12-13 | CLADRIBINE | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101278101 |
| 10320589 | 10039489 | 1.85 | 91 | null | 2020-06-03 | 2020-06-23 | POMALIDOMIDE | 02 | null | CISPLATIN + VINORELBINE | 100783916 |
| 10320619 | 10039491 | 1.69 | 62.55 | Palliative (P) | null | 2020-02-08 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100069274 |
| 10320620 | 10039492 | 1.6 | 73 | Disease modification (D) | 2019-07-14 | 2019-08-01 | Venetoclax | 02 | N | CISPLATIN + FLUOROURACIL | 100436240 |
| 10320674 | 10039494 | 1.64 | 0 | 03 | 2020-05-08 | 2020-05-22 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101130146 |
| 10320703 | 10039495 | 1.58 | 91 | Curative (C) | null | 2019-06-19 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 101179052 |
| 10320708 | 10039497 | 1.83 | 70.25 | null | 2016-04-20 | 2016-05-03 | DARATUMUMAB | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100748459 |
| 10320730 | 10039499 | 1.64 | null | Curative (C) | 2019-07-02 | 2019-07-02 | CHLORAMBUCIL + RITUXIMAB | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100750061 |
| 10320746 | 10039500 | 1.7 | 0 | null | 2019-12-06 | 2019-12-15 | CTD Attenuated (Thalidomide 100mg) | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101170457 |
| 10320797 | 10039501 | 1.59 | 80 | null | 2022-05-15 | 2022-05-15 | CHOP R - 21 days | N | null | CHOP R | 101456180 |
| 10320884 | 10039503 | 1.58 | 64.7 | Palliative (P) | 2019-11-29 | 2019-12-04 | CHOP - 21 days | 02 | N | VENETOCLAX | 101153253 |
| 10320918 | 10039505 | 1.66 | 56.1 | null | 2018-01-17 | 2018-01-25 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 101245090 |
| 10320924 | 10039506 | 1.6 | 82 | Adjuvant (A) | 2019-11-04 | 2019-11-07 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 101365832 |
| 10320926 | 10039507 | 0 | 73.9 | Adjuvant (A) | 2018-09-26 | 2018-10-03 | DABRAFENIB + TRAMETINIB | 01 | N | VENETOCLAX | 101751864 |
| 10321027 | 10039508 | null | 82.5 | Adjuvant (A) | 2019-04-17 | 2019-04-17 | Avelumab | 02 | null | AVELUMAB | 100329351 |
| 10321150 | 10039510 | 1.82 | null | Adjuvant (A) | null | 2018-11-02 | null | 02 | null | SUNITINIB | 101194068 |
| 10321153 | 10039511 | 1.86 | 48 | Curative (C) | 2020-02-23 | 2020-02-28 | BUSULFAN | 02 | N | SUNITINIB | 100579586 |
| 10321156 | 10039512 | 1.61 | null | 03 | 2017-08-31 | 2017-09-14 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100087989 |
| 10321197 | 10039513 | 1.64 | 65 | Curative (C) | 2019-02-11 | 2019-02-21 | Bortezomib (weekly) | 02 | Y | BORTEZOMIB | 100954496 |
| 10321340 | 10039515 | 1.79 | 79.25 | null | 2020-01-04 | 2020-01-05 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 100523280 |
| 10321407 | 10039516 | null | null | Adjuvant (A) | 2020-09-20 | 2020-10-10 | Cladribine (subcut) 5 days | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100229227 |
| 10321440 | 10039517 | null | 0 | null | 2019-12-01 | 2020-02-17 | NIVOLUMAB | N | null | NIVOLUMAB | 101177872 |
| 10321551 | 10039519 | null | 0 | null | 2017-12-13 | 2018-02-05 | Acalabrutinib | 02 | null | ACALABRUTINIB | 101705582 |
| 10321580 | 10039520 | 1.7 | 60 | 03 | 2017-12-19 | 2017-12-22 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 100547380 |
| 10321661 | 10039521 | 1.59 | 51.4 | Palliative (P) | 2017-08-25 | 2017-08-25 | DABRAFENIB + TRAMETINIB | 02 | N | CISPLATIN + VINORELBINE | 100687840 |
| 10321702 | 10039522 | null | null | 03 | 2018-06-29 | 2018-06-29 | FLUOROURACIL | N | N | FLUOROURACIL | 100664964 |
| 10321713 | 10039523 | null | null | Disease modification (D) | 2019-07-05 | 2019-07-06 | CISPLATIN + VINORELBINE | 02 | N | BCG | 101191639 |
| 10321748 | 10039525 | 1.76 | 57 | 03 | 2018-05-20 | 2018-05-20 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100699637 |
| 10321776 | 10039526 | 1.65 | 70.1 | null | 2019-10-27 | 2019-11-02 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 01 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101291534 |
| 10321955 | 10039528 | 1.8 | null | Palliative (P) | 2019-01-12 | 2019-01-19 | POMALIDOMIDE | 02 | null | POMALIDOMIDE | 100656948 |
| 10321991 | 10039529 | 1.7 | 47.3 | Palliative (P) | 2018-06-30 | 2018-07-05 | Avelumab | 02 | null | AVELUMAB | 100529791 |
| 10321996 | 10039530 | 1.67 | 73.2 | Palliative (P) | 2017-11-28 | 2018-12-01 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100345502 |
| 10322030 | 10039531 | 1.52 | 71.45 | Curative (C) | 2019-03-30 | 2019-07-13 | FEC 60 or 75 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100642397 |
| 10322130 | 10039534 | 1.56 | 117 | Disease modification (D) | 2019-01-04 | 2019-01-04 | TEMOZOLOMIDE | 02 | N | TEMOZOLOMIDE | 100330941 |
| 10322246 | 10039536 | 1.72 | null | null | 2019-07-15 | 2019-08-02 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101797206 |
| 10322281 | 10039537 | 1.6 | 80.2 | Palliative (P) | 2017-09-10 | 2017-09-19 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101070096 |
| 10322286 | 10039538 | 1.86 | 76.6 | Palliative (P) | 2017-10-19 | 2017-10-28 | BCG Intravesical | 02 | N | PAZOPANIB | 100704289 |
| 10322347 | 10039539 | null | null | Neo-adjuvant (N) | 2019-06-20 | 2019-07-03 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | POMALIDOMIDE | 100321544 |
| 10322503 | 10039541 | 1.65 | 69.7 | Disease modification (D) | 2014-10-17 | 2018-05-12 | Venetoclax | N | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100783070 |
| 10322573 | 10039543 | 1.69 | 77.9 | Curative (C) | 2013-12-31 | 2018-07-27 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101258980 |
| 10322578 | 10039544 | 1.56 | 72 | null | 2018-09-11 | 2018-09-21 | FEC + DOCETAXEL | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 100248871 |
| 10322592 | 10039545 | 1.73 | 78.9 | Palliative (P) | 2018-06-28 | 2018-07-04 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101522222 |
| 10322744 | 10039547 | 1.7 | 63.3 | 03 | 2019-01-16 | 2019-01-17 | Pazopanib | 02 | N | CAPECITABINE + CISPLATIN | 101032268 |
| 10322747 | 10039548 | 0 | 66.7 | Adjuvant (A) | 2018-10-18 | 2018-10-31 | FEC 100 + DOCETAXEL | N | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100560567 |